|
1
|
Tang XL, Rokosh G, Sanganalmath SK, Yuan
F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, et al: Intracoronary
administration of cardiac progenitor cells alleviates left
ventricular dysfunction in rats with a 30-day-old infarction.
Circulation. 121:293–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chimenti I, Smith RR, Li TS, Gerstenblith
G, Messina E, Giacomello A and Marbán E: Relative roles of direct
regeneration versus paracrine effects of human cardiosphere-derived
cells transplanted into infarcted mice. Circ Res. 106:971–980.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rufaihah AJ, Haider HK, Heng BC, Ye L, Tan
RS, Toh WS, Tian XF, Sim EK and Cao T: Therapeutic angiogenesis by
transplantation of human embryonic stem cell-derived
CD133+ endothelial progenitor cells for cardiac repair.
Regen Med. 5:231–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leri A, Kajstura J and Anversa P: Role of
cardiac stem cells in cardiac pathophysiology: A paradigm shift in
human myocardial biology. Circ Res. 109:941–961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williams AR and Hare JM: Mesenchymal stem
cells: Biology, pathophysiology, translational findings, and
therapeutic implications for cardiac disease. Circ Res.
109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oskouei BN, Lamirault G, Joseph C, Treuer
AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece
I and Hare JM: Increased potency of cardiac stem cells compared
with bone marrow mesenchymal stem cells in cardiac repair. Stem
Cells Transl Med. 1:116–124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ellison GM, Vicinanza C, Smith AJ, Aquila
I, Leone A, Waring CD, Henning BJ, Stirparo GG, Papait R, Scarfò M,
et al: Adult c-kit(pos) cardiac stem cells are necessary and
sufficient for functional cardiac regeneration and repair. Cell.
154:827–842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chimenti C, Kajstura J, Torella D, Urbanek
K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A,
Leri A, et al: Senescence and death of primitive cells and myocytes
lead to premature cardiac aging and heart failure. Circ Res.
93:604–613. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dimmeler S and Leri A: Aging and disease
as modifiers of efficacy of cell therapy. Circ Res. 102:1319–1330.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Urbanek K, Quaini F, Tasca G, Torella D,
Castaldo C, Nadal-Ginard B, Leri A, Kajstura J, Quaini E and
Anversa P: Intense myocyte formation from cardiac stem cells in
human cardiac hypertrophy. Proc Natl Acad Sci USA. 100:10440–10445.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Urbanek K, Torella D, Sheikh F, De Angelis
A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP,
Quaini F, et al: Myocardial regeneration by activation of
multipotent cardiac stem cells in ischemic heart failure. Proc Natl
Acad Sci USA. 102:8692–8697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burger-Kentischer A, Goebel H, Seiler R,
Fraedrich G, Schaefer HE, Dimmeler S, Kleemann R, Bernhagen J and
Ihling C: Expression of macrophage migration inhibitory factor in
different stages of human atherosclerosis. Circulation.
105:1561–1566. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calandra T, Echtenacher B, Roy DL, Pugin
J, Metz CN, Hültner L, Heumann D, Männel D, Bucala R and Glauser
MP: Protection from septic shock by neutralization of macrophage
migration inhibitory factor. Nat Med. 6:164–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morand EF, Bucala R and Leech M:
Macrophage migration inhibitory factor: An emerging therapeutic
target in rheumatoid arthritis. Arthritis Rheum. 48:291–299. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calandra T and Roger T: Macrophage
migration inhibitory factor: A regulator of innate immunity. Nat
Rev Immunol. 3:791–800. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morand EF, Leech M and Bernhagen J: MIF: A
new cytokine link between rheumatoid arthritis and atherosclerosis.
Nat Rev Drug Discov. 5:399–410. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu CM, Lai KW, Chen YX, Huang XR and Lan
HY: Expression of macrophage migration inhibitory factor in acute
ischemic myocardial injury. J Histochem Cytochem. 51:625–631. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miller EJ, Li J, Leng L, McDonald C,
Atsumi T, Bucala R and Young LH: Macrophage migration inhibitory
factor stimulates AMP-activated protein kinase in the ischaemic
heart. Nature. 451:578–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R
and Young LH: Cardiac macrophage migration inhibitory factor
inhibits JNK pathway activation and injury during
ischemia/reperfusion. J Clin Invest. 119:3807–3816. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stumptner-Cuvelette P and Benaroch P:
Multiple roles of the invariant chain in MHC class II function.
Biochim Biophys Acta. 1542:1–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leng L, Metz CN, Fang Y, Xu J, Donnelly S,
Baugh J, Delohery T, Chen Y, Mitchell RA and Bucala R: MIF signal
transduction initiated by binding to CD74. J Exp Med.
197:1467–1476. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohta S, Misawa A, Fukaya R, Inoue S,
Kanemura Y, Okano H, Kawakami Y and Toda M: Macrophage migration
inhibitory factor (MIF) promotes cell survival and proliferation of
neural stem/progenitor cells. J Cell Sci. 125:3210–3220. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schrans-Stassen B, Lue H, Sonnemans D,
Bernhagen J and Post M: Stimulation of vascular smooth muscle cell
migration by macrophage migration inhibitory factor. Antioxid Redox
Signal. 7:1211–1216. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong CJ, Huang B, Zhou Y, Cun YP, Liu LT,
Wang J, Li CQ, Pan Y and Wang H: Macrophage migration inhibitory
factor inhibits the migration of cartilage end plate-derived stem
cells by reacting with CD74. PLoS One. 7:e439842012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia W, Zhang F, Xie C, Jiang M and Hou M:
Macrophage migration inhibitory factor confers resistance to
senescence through CD74-dependent AMPK-FOXO3a signaling in
mesenchymal stem cells. Stem Cell Res Ther. 6(82)2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Palumbo S, Tsai TL and Li WJ: Macrophage
migration inhibitory factor regulates AKT signaling in hypoxic
culture to modulate senescence of human mesenchymal stem cells.
Stem Cells Dev. 23:852–865. 2014. View Article : Google Scholar
|
|
27
|
Ciuffreda L, Di Sanza C, Incani UC and
Milella M: The mTOR pathway: A new target in cancer therapy. Curr
Cancer Drug Targets. 10:484–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao N, Zhang Z, Jiang BH and Shi X: Role
of PI3K/AKT/mTOR signaling in the cell cycle progression of human
prostate cancer. Biochem Biophys Res Commun. 310:1124–1132. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morgensztern D and McLeod HL:
PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer
Drugs. 16:797–803. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smith AJ, Lewis FC, Aquila I, Waring CD,
Nocera A, Agosti V, Nadal-Ginard B, Torella D and Ellison GM:
Isolation and characterization of resident endogenous
c-Kit+ cardiac stem cells from the adult mouse and rat
heart. Nat Protoc. 9:1662–1681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Wang Y, Du W, Liu W, Liu F, Zhang
L, Zhang M, Hou M, Liu K, Zhang S and Yu B: Wnt1 inhibits hydrogen
peroxide-induced apoptosis in mouse cardiac stem cells. PLoS One.
8:e588832013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou M, Cui J, Liu J, Liu F, Jiang R, Liu
K, Wang Y, Yin L, Liu W and Yu B: Angiopoietin-like 4 confers
resistance to hypoxia/serum deprivation-induced apoptosis through
PI3K/Akt and ERK1/2 signaling pathways in mesenchymal stem cells.
PLoS One. 9:e858082014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Baydoun AR, Xu R, Deng L, Liu X,
Zhu W, Shi L, Cong X, Hu S and Chen X: Lysophosphatidic acid
protects mesenchymal stem cells against hypoxia and serum
deprivation-induced apoptosis. Stem Cells. 26:135–145. 2008.
View Article : Google Scholar
|
|
34
|
White DA, Su Y, Kanellakis P, Kiriazis H,
Morand EF, Bucala R, Dart AM, Gao XM and Du XJ: Differential roles
of cardiac and leukocyte derived macrophage migration inhibitory
factor in inflammatory responses and cardiac remodelling post
myocardial infarction. J Mol Cell Cardiol. 69:32–42. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beltrami AP, Urbanek K, Kajstura J, Yan
SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A,
Beltrami CA and Anversa P: Evidence that human cardiac myocytes
divide after myocardial infarction. N Engl J Med. 344:1750–1757.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Usui T, Yamagami S, Kishimoto S, Seiich Y,
Nakayama T and Amano S: Role of macrophage migration inhibitory
factor in corneal neovascularization. Invest Ophthalmol Vis Sci.
48:3545–3550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Chen T, Leng L, Fan J, Cao K, Duan
Z, Zhang X, Shao C, Wu M, Tadmori I, et al: MIF produced by bone
marrow-derived macrophages contributes to teratoma progression
after embryonic stem cell transplantation. Cancer Res.
72:2867–2878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chu L, Hao H, Luo M, Huang Y, Chen Z, Lu
T, Zhao X, Verfaillie CM, Zweier JL and Liu Z: Ox-LDL modifies the
behaviour of bone marrow stem cells and impairs their endothelial
differentiation via inhibition of Akt phosphorylation. J Cell Mol
Med. 15:423–432. 2011. View Article : Google Scholar
|
|
39
|
Zhou Y, Pan P, Yao L, Su M, He P, Niu N,
McNutt MA and Gu J: CD117-positive cells of the heart: progenitor
cells or mast cells? J Histochem Cytochem. 58:309–316. 2010.
View Article : Google Scholar :
|
|
40
|
Moran AE, Forouzanfar MH, Roth GA, Mensah
GA, Ezzati M, Flaxman A, Murray CJ and Naghavi M: The global burden
of ischemic heart disease in 1990 and 2010: the Global Burden of
Disease 2010 study. Circulation. 129:1493–1501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koga K, Kenessey A, Powell SR, Sison CP,
Miller EJ and Ojamaa K: Macrophage migration inhibitory factor
provides cardioprotection during ischemia/reperfusion by reducing
oxidative stress. Antioxid Redox Signal. 14:1191–1202. 2011.
View Article : Google Scholar
|
|
42
|
Ma H, Wang J, Thomas DP, Tong C, Leng L,
Wang W, Merk M, Zierow S, Bernhagen J, Ren J, et al: Impaired
macrophage migration inhibitory factor-AMP-activated protein kinase
activation and ischemic recovery in the senescent heart.
Circulation. 122:282–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Losordo DW and Dimmeler S: Therapeutic
angiogenesis and vasculogenesis for ischemic disease: part II:
cell-based therapies. Circulation. 109:2692–2697. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tongers J, Losordo DW and Landmesser U:
Stem and progenitor cell-based therapy in ischaemic heart disease:
Promise, uncertainties, and challenges. Eur Heart J. 32:1197–1206.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hilfiker-Kleiner D, Hilfiker A, Fuchs M,
Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z,
Podewski E, et al: Signal transducer and activator of transcription
3 is required for myocardial capillary growth, control of
interstitial matrix deposition, and heart protection from ischemic
injury. Circ Res. 95:187–195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Salh B, Wagey R, Marotta A, Tao JS and
Pelech S: Activation of phosphatidylinositol 3-kinase, protein
kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw
264.7 cells: Differential effects of rapamycin, Ly294002, and
wortmannin on nitric oxide production. J Immunol. 161:6947–6954.
1998.PubMed/NCBI
|
|
47
|
Karar J and Maity A: PI3K/AKT/mTOR pathway
in angiogenesis. Front Mol Neurosci. 4(51)2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Byrne AM, Bouchier-Hayes DJ and Harmey JH:
Angiogenic and cell survival functions of vascular endothelial
growth factor (VEGF). J Cell Mol Med. 9:777–794. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Choudhary S, Hegde P, Pruitt JR, Sielecki
TM, Choudhary D, Scarpato K, Degraff DJ, Pilbeam CC and Taylor JA
III: Macrophage migratory inhibitory factor promotes bladder cancer
progression via increasing proliferation and angiogenesis.
Carcinogenesis. 34:2891–2899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Amin MA, Volpert OV, Woods JM, Kumar P,
Harlow LA and Koch AE: Migration inhibitory factor mediates
angiogenesis via mitogen-activated protein kinase and
phosphatidylinositol kinase. Circ Res. 93:321–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Russell RR III, Li J, Coven DL, Pypaert M,
Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ and Young LH:
AMP-activated protein kinase mediates ischemic glucose uptake and
prevents postischemic cardiac dysfunction, apoptosis, and injury. J
Clin Invest. 114:495–503. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dayawansa NH, Gao XM, White DA, Dart AM
and Du XJ: Role of MIF in myocardial ischaemia and infarction:
insight from recent clinical and experimental findings. Clin Sci
(Lond). 127:149–161. 2014. View Article : Google Scholar
|
|
53
|
Gao XM, Liu Y, White D, Su Y, Drew BG,
Bruce CR, Kiriazis H, Xu Q, Jennings N, Bobik A, et al: Deletion of
macrophage migration inhibitory factor protects the heart from
severe ischemia-reperfusion injury: A predominant role of
anti-inflammation. J Mol Cell Cardiol. 50:991–999. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Luedike P, Hendgen-Cotta UB, Sobierajski
J, Totzeck M, Reeh M, Dewor M, Lue H, Krisp C, Wolters D, Kelm M,
et al: Cardioprotection through S-nitros(yl)ation of macrophage
migration inhibitory factor. Circulation. 125:1880–1889. 2012.
View Article : Google Scholar : PubMed/NCBI
|
